Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Reports summarize breast cancer research from Osaka University
July 9th, 2009
According to recent research from Suita, Japan, "Incidence of joint symptoms and bone fractures as well as changes in bone mineral density (BMD) in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole were investigated to determine whether there is an ethnic difference from Caucasian patients in the incidence of these adverse events of anastrozole. Adjuvant anastrozole was used to treat 348 postmenopausal breast cancer patients for a median period of 22 months." "Adverse events of anastrozole including joint symptoms, loss of BMD, and bone fracture were investigated by means of chart review. Joint symptoms developed in 96 (27.5%) patients....
Source: Women's Health Weekly (2009-07-09)
|
